[/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
FDA published a 10-page perspective on the key considertions for creating an effective Quality Overall Summary (QOS) in new drug and biologic applications. “This can be accomplished by assuring that the QOS is patient-focused, effectively summarizes the overall control strategy, and guides the regulator through the submission,” the report states.
[/membership]